セレネース錠０．７５ｍｇ
基本情報
| 項目 | 値 |
|---|---|
| DrugBank ID | DB00502 |
| エビデンスレベル | L5（計算予測のみ） |
| 予測適応症数 | 45 |
| 日本商品名（例） | セレネース細粒１％, セレネース細粒１％（選）, セレネース錠０．７５ｍｇ |
承認適応症（KEGG）
統合失調症、躁病
予測適応症（TxGNN）
以下は TxGNN モデルにより予測された潜在的新適応症です。スコアが高いほど関連性が高いと予測されています。
| # | 適応症 | スコア | ソース |
|---|---|---|---|
| 1 | schizoaffective disorder | 99% | DL |
| 2 | mental disorder | 99% | DL |
| 3 | Tourette syndrome | 99% | DL |
| 4 | schizophreniform disorder | 99% | DL |
| 5 | psychotic disorder | 99% | DL |
| 6 | schizophrenia | 99% | DL |
| 7 | congenital disorder of glycosylation with defective fucosylation | 99% | DL |
| 8 | retinal dystrophy with or without extraocular anomalies | 99% | DL |
| 9 | hydranencephaly (disease) | 99% | DL |
| 10 | myopia X-linked | 99% | DL |
| 11 | Charcot-Marie-Tooth disease, demyelinating, type 1G | 99% | DL |
| 12 | myopia 26, X-linked, female-limited | 99% | DL |
| 13 | syndromic myopia | 99% | DL |
| 14 | polymicrogyria, perisylvian, with cerebellar hypoplasia and arthrogryposis | 99% | DL |
| 15 | atypical glycine encephalopathy | 99% | DL |
| 16 | manic bipolar affective disorder | 99% | DL |
| 17 | early-onset schizophrenia | 99% | DL |
| 18 | treatment-refractory schizophrenia | 99% | DL |
| 19 | trichotillomania | 99% | DL |
| 20 | REM sleep behavior disorder | 99% | DL |
| 21 | psychosexual disorder | 99% | DL |
| 22 | attention deficit-hyperactivity disorder | 99% | DL |
| 23 | skeletal overgrowth-craniofacial dysmorphism-hyperelastic skin-white matter lesions syndrome | 99% | DL |
| 24 | neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal recessive | 99% | DL |
| 25 | postpartum psychosis | 99% | DL |
| 26 | substance-induced psychosis | 98% | DL |
| 27 | faciodigitogenital syndrome | 98% | DL |
| 28 | enuresis | 98% | DL |
| 29 | factitious disorder | 98% | DL |
| 30 | dissociative disorder | 98% | DL |
| 31 | distal 17p13.3 microdeletion syndrome | 98% | DL |
| 32 | attention deficit hyperactivity disorder, inattentive type | 98% | DL |
| 33 | hydrops-lactic acidosis-sideroblastic anemia-multisystemic failure syndrome | 98% | DL |
| 34 | major affective disorder | 97% | DL |
| 35 | bipolar disorder | 97% | DL |
| 36 | chondromyxoid fibroma | 97% | DL |
| 37 | specific developmental disorder | 97% | DL |
| 38 | drug/alcohol-induced mental disorder | 96% | DL |
| 39 | alcoholic psychosis | 96% | DL |
| 40 | Malan overgrowth syndrome | 95% | DL |
| 41 | tic disorder | 95% | DL |
| 42 | diabetes insipidus, nephrogenic, autosomal | 93% | DL |
| 43 | partial deletion of the short arm of chromosome 4 | 93% | DL |
| 44 | cognitive disorder | 91% | DL |
| 45 | impulse control disorder | 90% | DL |
免責事項
これらの予測は研究目的のみであり、医療アドバイスを構成するものではありません。 臨床応用には必ず適切な検証が必要です。